AzTrials
AzTrials

Anesthesia AwarenessANAPEDNCT05193747

The Depth of Paediatric Anaesthesia: Observational Trial

An observational study of Anesthesia Awareness, run by Brno University Hospital at 1 site in Czechia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Perioperative measurement of the Depth of anaesthesia is currently recommended part of daily anaesthesia good clinical practice. The optimal depth of anaesthesia measured by Bispectral index could be between 40-60. Read more about this study

Who is it for?
Ages 1 year to 18 years
Conditions the study is for
Anesthesia Awareness
What is being tested?
Anesthesia depth monitoring
How many people
100 participants
Where
1 siteCzechia
Study dates
14 Jan 2022to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 18 years
  • All sexes
  • Child, Adult

Study population: Paediatric patients (between 1 year -19 years) undergoing elective general anaesthesia with presumed duration over 1 hour will be eligible for inclusion.

Who may be able to join

  • Age 1 year-19 years
  • Elective general anaesthesia with presumed duration over 60 minutes
  • BIS monitor available

Who cannot join

  • Outside the age limits
  • Acute surgery
  • Presumed anaesthesia duration below 1 hour
  • Without the possibility of BIS monitoring
  • Patient indicated for sedation and mechanical ventilation after anesthesia

Trial locations and contacts

1 site in 1 country.

Jozef Klučka, assoc.prof.MD., Ph.D. contact

532234696 ext. +420

klucka.jozef@fnbrno.cz

Czechia1 site, 1 recruiting
  • Brno University Hospital

    Brno, South Moravian, 62500

    Petr Štourač, doc.MD.P.hD., 532234404 ext. 00420, stourac.petr@fnbrno.cz

    Jozef Klučka, MD, 532234696 ext. 00420, klucka.jozef@fnbrno.cz

    Recruiting

Other trials in Czechia

About this study

Perioperative measurement of the Depth of anaesthesia is currently recommended part of daily anaesthesia good clinical practice. The optimal depth of anaesthesia measured by Bispectral index could be between 40-60. The lower (over 60) depth of anaesthesia could be associated with accidental intraoperative episodes of awareness and deeper (below 40) anaesthesia could lead to higher adverse events or even haemodynamic instability.

Read the detailed description

The hypothesis of the trial is that during the perioperative period serious fluctuations outside the recommended target depth of anaesthesia could occur. These fluctuations and the cumulative time spent in the shallow (over 60 BIS) or deep (under 40 BIS) could be associated with postoperative complications like emergence delirium (PAED over 10, and PAED over 12- 2 measurement methods), postoperative nausea and vomiting (PONV) and other postoperative complications (respiratory, hemodynamic).

Paediatric patients (between 1 year -19 years) undergoing elective general anaesthesia with presumed duration over 1 hour will be eligible for inclusion. The patients will be screened for eligibility during the preanaesthesia visit in the anaesthesiology examination room. After the Ethics committee and registration of the study at clinicaltrials.gov, the patients will be enrolled - according to the trial design. There is a presumption that informed consent won't be needed for participation due to observational trial. The anaesthesia induction will be performed either inhalation or intravenous route. After anaesthesia induction BIS monitor will be placed on the forehead according to the manufacturer recommendation and the anaesthesia team will be blinded to BIS monitor during the whole case. The initial BIS tracing will be recorded starting the surgery initiation (defined as the depth of anesthesia by the anaesthesiologist to initiate surgical intervention) and ending with end of surgical intervention. The incidence of periods outside the recommended anaesthesia depth will be recorded (episode is defined by ≥ 30 seconds interval outside the predefined limits, the end of episode is defined by the return to recommended BIS level). The cumulative time spent outside the recommended BIS levels will be evaluated as the primary outcome measure. The anaesthesiologist's ability to respond to fluctuations defined as YES / NO response, type of intervention and latency of the anaesthesiologist's response to fluctuation will be evaluated. The BIS recording will be terminated at the time the surgical intervention is finished. After surgery/anaesthesia, the patient will be transferred to ICU or post-anaesthesia care unit (PACU), where the incidence of emergence delirium (defined by PEAD score over 10 and over 12 - according to 2 measurement methods) and the incidence of PONV will be recorded. Also, cumulative incidence of overall complication in the postoperative period (desaturation, the need for oxygen therapy, haemodynamic instability, arrhythmias (over 150/min, below 50/min, allergic reactions) will be recorded. In the case of a critical BIS value (≥90, ≤10), blinding will be interrupted due to patient safety and the value will be notified to the anesthesiology team and the event will be recorded as a critical event.

Being tested
Anesthesia depth monitoring
Keywords
Anesthesia, Awareness, Pediatric, Children
Medical subject headings
Intraoperative Awareness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anesthesia depth monitoringOther

    BIS monitor will be placed on the forehead according to the manufacturer recommendation and the anaesthesia team will be blinded to BIS monitor during the whole case. The initial BIS tracing will be recorded starting the surgery initiation (defined as the depth of anesthesia by the anaesthesiologist to initiate surgical intervention) and ending with end of surgical intervention.

Study groups in NCT05193747
Study groupRoleWhat they receive
Paediatric patients scheduled for general anesthesiaPaediatric patients (between 1 year -19 years) undergoing elective general anaesthesia with presumed duration over 1 hour will be eligible for inclusion
Receives: Other: Anesthesia depth monitoring

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cumulative time outside recommended BIS levels

    The cumulative time spent outside the recommended BIS levels will be evaluated

    Measured: intraoperatively

  2. Periods outside recommended BIS levels

    The incidence of periods outside the recommended anaesthesia depth will be recorded (episode is defined by ≥ 30 seconds interval outside the predefined limits, the end of episode is defined by the return to recommended BIS level).

    Measured: intraoperatively

Secondary outcomes (5)
  1. Ability to respond

    The anaesthesiologist's ability to respond to fluctuations defined as YES / NO response, type of intervention and latency of the anaesthesiologist's response to fluctuation will be evaluated.

    Measured: Intraoperatively

  2. Incidence of emergence delirium

    After surgery/anaesthesia, the patient will be transferred to ICU or PACU, where the incidence of emergence delirium (defined by PEAD over 10 and over 12 - 2 measurement methods) and the incidence of PONV will be recorded.

    Measured: 2 hours postoperatively

  3. Incidence of overall complications

    Cumulative incidence of overall complication in the postoperative period (desaturation, the need for oxygen therapy, haemodynamic instability, arrhythmias (over 150/min, below 50/min, allergic reactions) will be recorded.

    Measured: 2 hours postoperatively

  4. Delay to respond

    Latency of the anaesthesiologist's response to fluctuation - defined in seconds from the onset of fluctuation to the end of fluctuation = return to the recommended BIS level

    Measured: Intraoperatively

  5. Incidence of postoperative nausea and vomiting (PONV(

    Incidence of PONV at PACU

    Measured: 2 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2022
  2. Study start14 Jan 2022
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05193747
Sponsor's protocol ID
KDAR ANADEPTH 2022
Acronym
ANAPED
Status last verified
Mar 2023
First submitted
2 Jan 2022
Last updated
24 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia Awareness, run by Brno University Hospital at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jozef Klučka, assoc.prof.MD., Ph.D. (532234696 ext. +420, klucka.jozef@fnbrno.cz), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cumulative time outside recommended BIS levels (time frame: intraoperatively). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in